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We report a case of invasive candidiasis presenting as multiple lung nodules and cavitary lesions with
minimal pleural effusion. Candida infections of the lung are rare but can occur after hematologic
dissemination of the yeast from other body sites, such as the skin and the gastrointestinal and genito-
urinary tracts. Here, we describe the case of a 56-year-old female with a history of end-stage renal
disease (ESRD) who presented with fever, productive cough, and pulmonary nodules and cavitary lesions
seen on a chest computed tomography (CT). The patient's blood cultures were positive for Candida
zeylanoides.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Candida lung infections are extremely rare but occur due to
hematogenous spread of the yeast, rather than aspiration of
oropharyngeal secretions. Candidiasis usually presents as coloni-
zation, not infection [1], and its risk factors include immunosup-
pression, neutropenia, hematologic malignancy, long-term
antibiotic use, late sepsis, and total parenteral nutrition [2].
Radiologic presentation of Candida infections in the lung varies
from pneumonia, ground-glass opacity, miliary patterns, nodules,
micro-abscesses, thickening of the bronchial wall, and pleural
effusion with a rare ﬁnding of cavitary lesions [3,4].
The fourth most common cause of hospital-acquired blood-
stream infections in the United States is candidemia [5]. Invasive
candidiasis is associated with high mortality in adults, approxi-
mately 15%e25% of infected patients [6].
2. Case report
A 56-year-old womanwith ESRD presented to the ER with fever,
painful rash on the hands, and an abnormal blood culture reportEnd Stage Renal Disease.
had), sgarcia5@bronxleb.org
Ltd. This is an open access article uindicating growth of yeast identiﬁed 2 days prior to her visit. The
patient reported shortness of breath, a progressively worsening
cough that produced a small amount of non-bloody white sputum
for 2 weeks, and subjective fever and chills.
The patient had been receiving hemodialysis through a left-arm
arteriovenous graft, and her other co-morbidities included hyper-
tension and diabetes mellitus. She was referred to the hospital from
her dialysis center after yeast were identiﬁed in her blood cultures,
later identiﬁed as candida zeylanoides.
Physical examination revealed an obese female who appeared
alert and comfortable. She was febrile at 102 F, her blood pressure
was 156/86 mmHg, and her oxygen saturationwas 98% on room air.
The left-arm arteriovenous graft had good thrill, although a further
skin exam revealed 1-mm violaceous macular lesions on the palm
and ventral aspects of 4th and 5th ﬁngers of her left hand (Fig. 1).
Basilar crackles were noted upon auscultation with normal
heart sounds and nomurmurs. Fundoscopic examination of the eye
revealed hypertensive retinopathy, and the patient had a White,
hypo-pigmented inferotemporal lesion suggestive of fungal cho-
rioretinitis (Fig. 2).
Other results from the initial physical examination were
unremarkable.
Laboratory values were signiﬁcant for leukocytosis with a WBC
count of 1.34  104/mL that increased to 1.82  104/mL on day 3. The
patient's blood cultures were positive for yeast.
Ultrasound image showed ﬂuid collection around the patentnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. 1-mm violaceous nodules on the palm.
Fig. 2. White, hypo-pigmented inferotemporal lesion suggestive of fungal
chorioretinitis.
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Fine needle aspirationwas done under ultrasound guidance and
culture grew candida zeylanoides. Vascular surgeon did excision ofFig. 3. Ultrasound image [3A] showing anechoic ﬂuid collection (blue arrow) around the ar
arrow). (For interpretation of the references to colour in this ﬁgure legend, the reader is reinfected arteriovenous graft and placed temporary Shiley catheter
for hemodialysis. Later when blood cultures were negative, patient
had permanent permacath.
A transesophageal echocardiogramwas negative for vegetation,
but a chest CT showed peripheral nodular lesions suggestive of
infective emboli (Fig. 4).
A subsequent bronchoscopy with bronchoalveolar lavage
revealed white exudate (Fig. 5), and tissue cultures collected during
a transbronchial biopsy yielded Candida zeylanoides (Fig. 6).
The mycology laboratory afﬁliated with our hospital uses VITEK
2 system for identiﬁcation of Candida species which was zeyla-
noides in our case. VITEK 2 system is a rapid method for the
identiﬁcation of medically important yeasts and yeast-like organ-
isms. VITEK ID-YST card along with VITEK 2 system identify the
yeast in 15 hours. The card consist of 47 biochemical reactions to
identify yeast and the system uses ﬂuorescenceebased technology.
Her negative test for serum precipitins to Aspergillus fumigatus
and Aspergillus niger excluded concomitant aspergillosis.
The patient was started on caspofungin, which was later
replaced with ﬂuconazole per recommendations by the Infectious
disease team. Repeat blood cultures were negative for fungal
growth. The patient was discharged from the hospital with orders
to complete 6 weeks of parenteral ﬂuconazole during hemodialysis
3 times a week. Patient completed antifungal therapy as outpatient
and being followed with us in dialysis center.3. Discussion
Invasive candidiasis occurs when Candida species enter the
bloodstream and spread to other body sites. Risk factors for invasive
candidiasis include renal failure, surgical procedures, prolonged
central venous catheter placement, immunosuppression neu-
tropenia, hematologic malignancy, long-term use of antibiotics, late
sepsis, and total parenteral nutrition [2,7]. For example, a study by
Ostrosky-Zeichner showed 10% of patients in Intensive care units
have increased risk for candidemia secondary to central venous
catheter placement, prolonged antibiotic and systemic steroid use,
and major surgeries [8]. Candida species account for 9% of all in-
fections in intensive care unit patients, although the frequency of
opportunistic Candida infections in AIDS patients has decreased
with improved antiretroviral therapy [9].teriovenous graft and [3B] doppler ultrasound showing patent arteriovenous graft (red
ferred to the web version of this article.)
Fig. 4. Chest CT axial [4A] and sagittal [4B] views showing multiple peripheral pulmonary cavitary nodules.
Fig. 5. Bronchoalveolar lavage yielding white exudate.
Fig. 6. Gram stain of bronchoalveolar lavage showing budding yeast cells.
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ence in respiratory samples is often regarded as contamination.
According to Kassner et al., three histologic forms of pulmonary
candidiasis occur: embolic, disseminated, and bronchopulmonary
[10]. A study by el-Ebiary determined that the incidence of Candida-associated pneumonia is 8%, and its colonization pattern is usually
uniform throughout the lung [11]. Bronchoalveolar lavage, cyto-
logic and morphologic analyses with accompanying cultures [12],
and histopathology showing Candida invasion of the lung (the gold
standard of pulmonary Candida diagnosis) [13] should be per-
formed to reliably bronchopulmonary and disseminated Candida
infection.
Azoulay et al. found that intensive care unit patients on me-
chanical ventilation for more than two days often exhibited
Candida colonization in the respiratory tract, and other studies
showed that Candida colonization increased risk of ventilator-
associated, multidrug-resistant bacterial pneumonia [1,14]. More-
over, Delisle et al., observed that respiratory tract colonizationwith
Candidawas also associatedwith increased hospital stay length and
mortality rates [15]. One potential explanation is that Candida-
related immune dysfunction enhances susceptibility to other res-
piratory pathogens.
Lung transplant recipients have a high incidence of Candida
colonization in the trachea and bronchial secretions. In a study
performed by Brooks et al., one autopsy-diagnosed case of invasive
Candida pneumonia involving both lungs in a transplant patient
had repeatedly produced Candida from pre-mortem sputum and
bronchoalveolar lavage samples. Candida colonizes 86% of lung
transplant recipients, while other fungal species, such as Aspergillus
spp., are only found in 25% of recipients [16]. As the yeast colonize
the upper airway, sputum cultures become unreliable for Candida
diagnosis, and cultures of blood, body cavities, and/or sterile organ
sites are then required for its deﬁnitive identiﬁcation [17].
Franquet et al. found that 70% of patients with pulmonary
candidiasis presented with nodules sometimes surrounded by
discrete areas of ground-glass opacities [3]. Fine nodular patterns
seen after radiography could be due to superimposed pulmonary
pathology or may represent disseminated candidiasis [18]. Pul-
monary candidiasis may also present as an isolated parenchymal
pulmonary nodule without recurrent infections in patients with
low immunoglobulin G levels [19]. Candidiasis may also present as
dermatitis, esophagitis, thrush, peritonitis, mediastinitis, endo-
carditis, septic arthritis, vulvovaginal candidiasis, and osteomyelitis
[20]. Nodular cavitary pneumonia presentation is rare but was seen
in our clinical case. Vision-threatening ﬁndings of disseminated
candidiasis, such as endophthalmitis and chorioretinitis, are seen in
10% of patients [21].
One other case report by Yasuda et al. describes invasive
candidiasis that presented as multiple pulmonary cavitary lesions
[22]. Our patient had features of disseminated candidiasis,
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cavitary lesions of the lung. However, the source of infection in our
case was an infected arteriovenous ﬁstula, rather than an infected
central venous catheter as described in their case.
Treatment of Candida in sputum and bronchoalveolar lavage
exudate alone is not recommended, although patients with
disseminated candidiasis should be treated. If Candida is found in
respiratory samples, treatment is mandated only if other risk fac-
tors and sepsis are present [23]. Leon et al. showed that a Candida
score greater than 2.5 accurately identiﬁed patients who would
beneﬁt from early antifungal treatment (sensitivity 81%, speciﬁcity
74%). Candida score calculator is used to determine the likelihood of
invasive candidiasis versus colonization in non neutropenic criti-
cally ill patient. Candida score comprise of severe sepsis (2 points),
total parenteral nutrition (1 point), initial surgery (1 point),
multifocal candida colonization (1 point) in patients. These are the
predictors of proven candida infection. Our patient had severe
sepsis (2 point) andmultifocal candida colonization (1 point) which
lead to score of 3. Candida score of 3 has 8.5% risk of invasive
candidiasis without treatment [24].
The most common antifungal agents used for treatment of
candidemia are the echinocandins (casponfungin, micafungin,
anidulafungin) and azoles (ﬂuconazole, itraconazole and vor-
iconazole). Polyenes (amphotericin B dexoycholate and lipid for-
mulations of amphotericin B) are used less often secondary to risk
of toxicity [25].
We diagnosed our case as invasive, disseminated candidiasis by
the patient's positive blood cultures, eye and skin lesions, and chest
CT ﬁndings. Aspergillus precipitin detects the type and quantity of
speciﬁc aspergillus antibodies in blood. Antibodies are immuno-
globulin proteins made by the immune system in response to an-
tigens which is aspergillus. The aspergillus precipitin test looks for
IgG, IgM, IgE antibodies in blood. Our case serum precipitin was
negative. So aspergillus which is common fungal infection of lung
was excluded [26].
4. Conclusion
Respiratory tract Candida colonization often leads to poor clin-
ical outcomes and is independently associated with increased
hospital stay length and development of complications. Delayed
initiation of therapy for invasive candidiasis results in considerably
increased mortality. Our case report emphasizes the need for early,
comprehensive diagnosis of disseminated candidiasis and initiation
of appropriate antifungal treatment for clearance of the infection.
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